According to some researchers, the immune system appears to play a very prominent role in the triple negative BC setting (ER-negative, PR-negative, and HER2-negative), and has a limited role in the endocrine sensitive setting (ER+ BC) (424, 425). The gene discussed is ERBB2; the disease is breast cancer.